» Articles » PMID: 25211071

The Integrative Human Microbiome Project: Dynamic Analysis of Microbiome-host Omics Profiles During Periods of Human Health and Disease

Overview
Publisher Cell Press
Date 2014 Sep 12
PMID 25211071
Citations 246
Affiliations
Soon will be listed here.
Abstract

Much has been learned about the diversity and distribution of human-associated microbial communities, but we still know little about the biology of the microbiome, how it interacts with the host, and how the host responds to its resident microbiota. The Integrative Human Microbiome Project (iHMP, http://hmp2.org), the second phase of the NIH Human Microbiome Project, will study these interactions by analyzing microbiome and host activities in longitudinal studies of disease-specific cohorts and by creating integrated data sets of microbiome and host functional properties. These data sets will serve as experimental test beds to evaluate new models, methods, and analyses on the interactions of host and microbiome. Here we describe the three models of microbiome-associated human conditions, on the dynamics of preterm birth, inflammatory bowel disease, and type 2 diabetes, and their underlying hypotheses, as well as the multi-omic data types to be collected, integrated, and distributed through public repositories as a community resource.

Citing Articles

Recent advances in deep learning and language models for studying the microbiome.

Yan B, Nam Y, Li L, Deek R, Li H, Ma S Front Genet. 2025; 15:1494474.

PMID: 39840283 PMC: 11747409. DOI: 10.3389/fgene.2024.1494474.


PhyloMix: enhancing microbiome-trait association prediction through phylogeny-mixing augmentation.

Jiang Y, Liao D, Zhu Q, Lu Y Bioinformatics. 2025; 41(2).

PMID: 39799515 PMC: 11849959. DOI: 10.1093/bioinformatics/btaf014.


Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.

Zhang Z, Liang Y, Mo S, Zhao M, Li Y, Zhang C Physiol Rep. 2024; 13(1):e70174.

PMID: 39739369 PMC: 11685845. DOI: 10.14814/phy2.70174.


The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease.

Wang Z, Kaplan R, Burk R, Qi Q Int J Mol Sci. 2024; 25(22).

PMID: 39596404 PMC: 11594421. DOI: 10.3390/ijms252212337.


Wise Roles and Future Visionary Endeavors of Current Emperor: Advancing Dynamic Methods for Longitudinal Microbiome Meta-Omics Data in Personalized and Precision Medicine.

Oh V, Li R Adv Sci (Weinh). 2024; 11(47):e2400458.

PMID: 39535493 PMC: 11653615. DOI: 10.1002/advs.202400458.


References
1.
Loftus Jr E . Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6):1504-17. DOI: 10.1053/j.gastro.2004.01.063. View

2.
Qin J, Li R, Raes J, Arumugam M, Burgdorf K, Manichanh C . A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464(7285):59-65. PMC: 3779803. DOI: 10.1038/nature08821. View

3.
Cohen S, Kamarck T, Mermelstein R . A global measure of perceived stress. J Health Soc Behav. 1983; 24(4):385-96. View

4.
Maier T, Guell M, Serrano L . Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009; 583(24):3966-73. DOI: 10.1016/j.febslet.2009.10.036. View

5.
Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, Engstrand L . Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2008; 15(5):653-60. DOI: 10.1002/ibd.20783. View